Histologic grading and immuno-histochemical evaluation of estrogen receptor
(ER), progesterone receptor (PR), human epidermal growth factor receptor 2
(HER-2), and Ki-67 proliferation index play a crucial role in increasing the
differential diagnostic value among various types of breast carcinoma.